BCL2 and endometrial carcinoma: For example, miR-125b-5p can enhance gallbladder cancer cell sensitivity to chemotherapy by downregulating BCL2 expression 26, while CDKN2B-AS1 modulates the miR-125a-5p/BCL2 axis in endometrial carcinoma to enhance paclitaxel sensitivity 27.